QUALITY OF HEALTH TECHNOLOGY ASSESSMENT REPORTS IN THE REPUBLIC OF KAZAKHSTAN
Introduction. Health technology assessment (HTA) is carried out to inform decision makers about the effectiveness and the need to cover it within the state budget. As a result, the quality of the prepared HTA reports is an important issue.
The aim of our study is to examine the quality of HTA reports prepared in Kazakhstan.
Methods. To study the quality of the HTA reports, we used an international checklist prepared by the International Network of Agencies for Health Technology Assessment. This checklist consists of 14 questions, the answers of which should be reflected in the HTA report. Two independent researchers analyzed reports for the period from 2017 to 2021.
Results. It can be seen that the quality of HTA reports was improved over the period given. Reports which prepared from 2017 to 2019, did not fully include information on conflicts of interest, as well as the HTA report preparation process. However, from 2020, more detailed information in the HTA reports included. In addition, HTA reports most often focused on cost-effectiveness issues, while ethical, legal and social aspects were very rarely studied.
Conclusion. Our analysis shows a positive trend in improving the quality of HTA reports. In the future the preparation of HTA reports need to take into account information relate to legal issues, as well as organizational, ethical and social aspects.
Lyazzat A. Kulembekova1, https://orcid.org/0000-0003-0237-1975
Lyazzat K. Kosherbaeva1, https://orcid.org/0000-0001-8376-4345
Aziza M. Imamatdinova1, https://orcid.org/0000-0003-2233-4522
Adilet B. Tabarov2, https://orcid.org/0000-0001-5156-8489
Anuar D. Akhmetzhan1, https://orcid.org/0009-0009-7451-9706
1 Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan;
2 Salidat Kairbekova National research center for health development, Astana, Republic of Kazakhstan.
1. A checklist for health technology assessment reports. INAHTA HTA Checklist, 2007. https://www.inahta.org/wp-content/uploads/2014/04/INAHTA_HTA_Checklist_English.pdf (accessed March 31, 2023)
2. Baghbanian A., Merlin T., Carter D., Wang S. Methods for the health technology assessment of complex interventions: a protocol for a scoping review // BMJ Open. 2020 Nov 30;10(11):e039263. doi: 10.1136/bmjopen-2020-039263.
3. Bossi E., Tringali M., Colombo P., Mazzali C., Puleo G., Caruggi M., Branchi M., Odone A. Quality Assessment of HTA reports: a Critical Appraisal Toolkit within an institutional HTA program // European Journal of Public Health, Volume 30, Issue Supplement_5, September 2020, ckaa166.585, https://doi.org/10.1093/eurpub/ckaa166.585 (accessed March 31, 2023)
4. Cacciatore P., Specchia M.L., Solinas M.G., Ricciardi W., Damiani G. The organizational domain in HTA reports: towards a technology-oriented assessment // Eur J Public Health. 2020 Apr 1;30(2):219-223. doi: 10.1093/eurpub/ckz173.
5. Drummond M.F., Schwartz J.S., Jönsson B., Luce B.R., Neumann P.J., Siebert U. et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions // Int J Technol Assess Health Care. 2008. 24(3):244–58. doi:10.1017/S0266462308080343
6. Fattore G., Maniadakis N., Mantovani L.G., Boriani G. Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology // Europace. 2011 May; 13 Suppl 2:ii49-53. doi: 10.1093/europace/eur083.
7. Hailey D. Toward transparency in health technology assessment: a checklist for HTA reports // Int J Technol Assess Health Care. 2003 Winter, 19(1):1-7. doi: 10.1017/s0266462303000011.
8. International Network of Agencies for Health Technology Assessment. The International Network of Agencies for Health Technology Assessment. [Online]; 2013 http://www.inahta.net/hta (accessed March 31, 2023)
9. Kristensen F.B., Nielsen C.P., Panteli D. Regulating the input – Health Technology Assessment. In: Busse R, Klazinga N, Panteli D, et al., editors. Improving healthcare quality in Europe: Characteristics, effectiveness and implementation of different strategies [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2019. (Health Policy Series, No. 53.) 6. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549272/ (accessed March 31, 2023)
10. Legault G.A., Gagnon H., Parent M., Bellemare C.A., Béland J.P., Kocsis-Bédard S., Bernier L., Dagenais P., Daniel C.É., Patenaude J. Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review // Int J Technol Assess Health Care. 2021 Apr 26;37(1):e61. doi: 10.1017/S0266462321000325
11. Muratov S., Hailey D., Foerster V., Brady B., Juzwishin D., la Fleur P., McGowan J. Mentoring a health technology assessment initiative in Kazakhstan // Int J Technol Assess Health Care. 2014 Apr;30(2):147-52. doi: 10.1017/S0266462314000087.
12. O'Rourke B., Oortwijn W., Schuller T. International Joint Task Group. The new definition of health technology assessment: A milestone in international collaboration // Int J Technol Assess Health Care. 2020 Jun;36(3):187-190. doi: 10.1017/S0266462320000215.
13. Tanvejsilp P., Ngorsuraches S. Defining the scope of health technology assessment and types of health economic evaluation // J Med Assoc Thai. 2014 May;97 Suppl 5:S10-6.
14. Widrig D., Tag B. HTA and its legal issues: a framework for identifying legal issues in health technology assessment // Int J Technol Assess Health Care. 2014 Dec;30(6):587-94. doi: 10.1017/S0266462314000683.
Number of Views: 73
Category of articles:
Original articles
Bibliography link
Kulembekova L.A., Kosherbaeva L.K., Imamatdinova A.M., Tabarov A.B., Akhmetzhan A.D. Quality of health technology assessment reports in the Republic of Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 4, pp. 158-122. doi 10.34689/SH.2023.25.4.020Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS